These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 16501291
1. Clinical significance of the electrophysiologic study (EPS)-guided therapy for the secondary prevention of ventricular tachycardia. Yuge M, Niwano S, Moriguchi M, Sasaki T, Hirasawa S, Imaki R, Sato D, Izumi T. Circ J; 2006 Mar; 70(3):268-72. PubMed ID: 16501291 [Abstract] [Full Text] [Related]
2. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate. AbdelWahab A, Sapp J. Curr Cardiol Rep; 2017 Sep 13; 19(11):105. PubMed ID: 28900864 [Abstract] [Full Text] [Related]
3. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies. Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD. J Cardiovasc Electrophysiol; 2012 Mar 13; 23(3):296-301. PubMed ID: 21955243 [Abstract] [Full Text] [Related]
4. Ventricular tachyarrhythmia recurrence in primary versus secondary implantable cardioverter-defibrillator patients and role of electrophysiology study. Zaman S, Sivagangabalan G, Chik W, Stafford W, Hayes J, Denman R, Young G, Sanders P, Kovoor P. J Interv Card Electrophysiol; 2014 Dec 13; 41(3):195-202. PubMed ID: 25267274 [Abstract] [Full Text] [Related]
5. Electrophysiologic parameters to predict clinical recurrence of ventricular tachycardia in patients under electrophysiologic study-guided effective pharmacological therapy. Niwano S, Yamaura M, Yoshizawa N, Moriguchi M, Kitano Y, Aizawa Y, Izumi T. Jpn Circ J; 1999 Sep 13; 63(9):674-80. PubMed ID: 10496481 [Abstract] [Full Text] [Related]
6. Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators. Gillis AM, Sheldon RS, Wyse DG, Duff HJ, Cassidy MR, Mitchell LB. J Cardiovasc Electrophysiol; 2003 May 13; 14(5):492-8. PubMed ID: 12776866 [Abstract] [Full Text] [Related]
7. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study. Giorgberidze I, Saksena S, Krol RB, Munsif AN, Kolettis T, Mathew P, Varanasi S, Prakash A, Delfaut P, Lewis CB. Am J Cardiol; 1997 Sep 11; 80(5B):3F-9F. PubMed ID: 9291444 [Abstract] [Full Text] [Related]
8. Role of electrophysiologic study (EPS)-guided preventive therapy for the management of ventricular tachyarrhythmias in patients with heart failure. Niwano S, Fukaya H, Yuge M, Imaki R, Hirasawa S, Sasaki T, Yumoto Y, Inomata T, Izumi T. Circ J; 2008 Feb 11; 72(2):268-73. PubMed ID: 18219165 [Abstract] [Full Text] [Related]
9. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol. Leite LR, Fenelon G, Simoes A, Silva GG, Friedman PA, de Paola AA. J Cardiovasc Electrophysiol; 2003 Jun 11; 14(6):567-73. PubMed ID: 12875414 [Abstract] [Full Text] [Related]
11. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ, MADIT II Study Investigators. J Am Coll Cardiol; 2006 Jan 03; 47(1):98-107. PubMed ID: 16386671 [Abstract] [Full Text] [Related]
12. Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Raitt MH, Klein RC, Wyse DG, Wilkoff BL, Beckman K, Epstein AE, Coromilas J, Friedman PL, Martins J, Ledingham RB, Greene HL, Antiarrhythmics Versus Implantable Defibrillators Investigators. Am J Cardiol; 2003 Apr 01; 91(7):812-6. PubMed ID: 12667566 [Abstract] [Full Text] [Related]
14. Significance of repeat programmed ventricular stimulation at electrophysiology study for arrhythmia prediction after acute myocardial infarction. Zaman S, Narayan A, Thiagalingam A, Sivagangabalan G, Thomas S, Ross DL, Kovoor P. Pacing Clin Electrophysiol; 2014 Jul 01; 37(7):795-802. PubMed ID: 24666010 [Abstract] [Full Text] [Related]
15. Postoperative ventricular arrhythmias after cardiac surgery: immediate- and long-term significance. Brembilla-Perrot B, Villemot JP, Carteaux JP, Haouzi A, Amrein D, Schöth B, Houriez P, Beurrier D, Djaballah K, Vançon AC, Nippert M. Pacing Clin Electrophysiol; 2003 Feb 01; 26(2 Pt 1):619-25. PubMed ID: 12710323 [Abstract] [Full Text] [Related]
16. Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial. Willems S, Tilz RR, Steven D, Kääb S, Wegscheider K, Gellér L, Meyer C, Heeger CH, Metzner A, Sinner MF, Schlüter M, Nordbeck P, Eckardt L, Bogossian H, Sultan A, Wenzel B, Kuck KH, BERLIN VT Investigators. Circulation; 2020 Mar 31; 141(13):1057-1067. PubMed ID: 32000514 [Abstract] [Full Text] [Related]
17. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study. Kowey PR, Crijns HJ, Aliot EM, Capucci A, Kulakowski P, Radzik D, Roy D, Connolly SJ, Hohnloser SH, ALPHEE Study Investigators. Circulation; 2011 Dec 13; 124(24):2649-60. PubMed ID: 22082672 [Abstract] [Full Text] [Related]